Method for the treatment of amyloidoses

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8895004
APP PUB NO 20110130549A1
SERIAL NO

12529467

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a method for the treatment of an amyloidosis such as Alzheimer's disease in a subject in need thereof, characterized in that it comprises administering an inhibitor of the interaction between Aβ globulomer and the P/Q type voltage-gated presynaptic calcium channel to said subject.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ABBVIE DEUTSCHLAND GMBH & CO KG

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Barghorn, Stefan Mannheim, DE 33 596
Bruhl, Claus Schonau, DE 3 9
Draguhn, Andreas Heidelberg, DE 3 9
Ebert, Ulrich Mannheim, DE 33 642
Grimm, Christine Leimen, DE 4 5
Gross, Gerhard Speyer, DE 54 449
Hillen, Heinz Hassloch, DE 44 705
Krantz, Carsten Allschwil, DE 7 105
Nimmrich, Volker Heidelberg, DE 10 84

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 25, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00